Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
14 May 24
8-K
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
13 May 24
8-K
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
1 May 24
DEFA14A
Additional proxy soliciting materials
29 Apr 24
DEF 14A
Definitive proxy
29 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
21 Mar 24
8-K
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
2 Jan 24
S-8
Registration of securities for employees
15 Dec 23
8-K
Departure of Directors or Certain Officers
8 Dec 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
7 Nov 23
8-K
Other Events
26 Sep 23
8-K
Other Events
19 Sep 23
8-K
Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations
6 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
8 Aug 23
8-K
Other Events
26 Jul 23
8-K
Departure of Directors or Certain Officers
23 Jun 23
8-K
Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
22 May 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Journey Medical Corporation Reports Full-Year 2022 Financial Results and Recent Corporate Highlights
29 Mar 23
424B3
Prospectus supplement
17 Feb 23
424B3
Prospectus supplement
17 Feb 23
EFFECT
Notice of effectiveness
27 Jan 23
CORRESP
Correspondence with SEC
24 Jan 23
8-K
Journey Medical Corporation Appoints Joseph Benesch as Interim Chief Financial Officer
20 Jan 23
UPLOAD
Letter from SEC
5 Jan 23
8-K
Entry into a Material Definitive Agreement
3 Jan 23
S-3
Shelf registration
30 Dec 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
10 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
8-K
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
9 Aug 22
8-K
Departure of Directors or Certain Officers
22 Jul 22
Latest ownership filings
4
LINDSAY A MD ROSENWALD
27 Mar 24
4
Claude Maraoui
25 Mar 24
4
Justin Adam Smith
25 Mar 24
4
LINDSAY A MD ROSENWALD
25 Mar 24
4
Joseph Benesch
23 Feb 24
4
Jeffrey Paley
8 Dec 23
4
Jeffrey Paley
29 Nov 23
4
Justin Adam Smith
17 Oct 23
4
Jeffrey Paley
10 Oct 23
4
Jeffrey Paley
25 Sep 23
4
Claude Maraoui
8 Sep 23
4
LINDSAY A MD ROSENWALD
8 Sep 23
4
Neil Herskowitz
25 Jul 23
4
Jeffrey Paley
25 Jul 23
4
Justin Adam Smith
25 Jul 23
4
Miranda Jayne Toledano
25 Jul 23
4
Claude Maraoui
25 Jul 23
4
Joseph Benesch
25 Jul 23
4
Claude Maraoui
18 May 23
4/A
Paolantonio Ernest Robert De
1 Mar 23
4
Joseph Benesch
23 Feb 23
3
Joseph Benesch
31 Jan 23
SC 13G/A
B. Riley Financial, Inc.
29 Dec 22
4
Paolantonio Ernest Robert De
6 Oct 22
SC 13G
Fortress Biotech, Inc.
17 Aug 22
4
LINDSAY A MD ROSENWALD
25 Jul 22
4
Justin Adam Smith
25 Jul 22
4
Jeffrey Paley
25 Jul 22
4
Neil Herskowitz
25 Jul 22
4
Miranda Jayne Toledano
25 Jul 22
4
Claude Maraoui
25 Jul 22
4
Paolantonio Ernest Robert De
25 Jul 22
3
LINDSAY A MD ROSENWALD
25 Jul 22
4
Neil Herskowitz
4 Apr 22
4
Miranda Jayne Toledano
4 Apr 22
4
Jeffrey Paley
4 Apr 22
4
Justin Adam Smith
4 Apr 22
4
Paolantonio Ernest Robert De
4 Apr 22
3/A
Claude Maraoui
4 Apr 22
SC 13G
B. Riley Financial, Inc.
11 Feb 22